EAM Investors’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-73,920
Closed -$785K 334
2024
Q2
$785K Buy
+73,920
New +$787K 0.13% 189
2023
Q4
Sell
-181,957
Closed -$1.78M 381
2023
Q3
$1.78M Buy
+181,957
New +$1.46M 0.34% 127
2019
Q2
Sell
-72,702
Closed -$747K 317
2019
Q1
$747K Buy
+72,702
New +$652K 0.18% 216
2016
Q2
Sell
-206,758
Closed -$1.06M 366
2016
Q1
$1.06M Sell
206,758
-7,281
-3% -$39.4K 0.17% 229
2015
Q4
$1.38M Buy
+214,039
New +$1.41M 0.18% 216

Other funds holding ULBI

EAM Investors's ULBI Position: Q3 2024 in Review

EAM Investors sold out of Ultralife (ULBI) in Q3 2024, closing a stake of 73,920 shares — an estimated $785K sold.

EAM Investors first reported a position in ULBI in Q4 2015 and held it in 5 quarters. The position peaked at $1.78M in Q3 2023. 74 funds tracked by Wall St. Rank hold ULBI as of Q3 2024.

  • EAM Investors reported no remaining Ultralife position as of Q3 2024 after selling out during the quarter.
  • EAM Investors sold 73,920 Ultralife shares in Q3 2024, an estimated $785K.
  • EAM Investors first reported a position in Ultralife in Q4 2015 and held it in 5 quarters.
  • EAM Investors's Ultralife position peaked at $1.78M in Q3 2023.
  • 74 funds tracked by Wall St. Rank held Ultralife as of Q3 2024.

Based on EAM Investors's 13F filing for Q3 2024, filed 13 Nov 2024.